Pain Management Programs for Hip Pain

(HIPS-RCT Trial)

KJ
Overseen ByKate Jochimsen, PhD, ATC
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Massachusetts General Hospital
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores two video-based programs, HIPS-1 and HIPS-2, for managing chronic hip pain not caused by arthritis. Participants will either learn relaxation and pain coping skills or receive education on a healthy lifestyle, including exercise, sleep, and nutrition tips. The researchers aim to determine which program is more feasible and acceptable for patients. Individuals who have experienced hip pain for over three months, are fluent in English, and find their pain affects their physical activity might be suitable for this trial. As an unphased trial, this study offers participants a unique opportunity to contribute to innovative approaches in managing chronic hip pain.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research has shown that both the HIPS-1 and HIPS-2 programs are safe and well-tolerated for individuals with chronic hip pain. Studies have found that non-surgical treatments like physical therapy, included in these programs, typically have very few side effects.

HIPS-1 emphasizes relaxation and coping skills. Research indicates that mind-body techniques are generally very safe and rarely cause any issues. Participants often report improved stress management without major negative effects.

HIPS-2 provides education on healthy lifestyle choices. Studies confirm that guidance on exercise, sleep, and nutrition is not only safe but also beneficial. These recommendations adhere to well-known public health guidelines, ensuring they are both trustworthy and safe. Overall, both programs have demonstrated safety with little to no risk of negative effects in similar contexts.12345

Why are researchers excited about this trial?

Researchers are excited about the HIPS-1 and HIPS-2 programs because they offer a novel approach to managing hip pain through live-video sessions, unlike traditional in-person physical therapy. HIPS-1 uniquely combines mind-body interventions with relaxation and coping skills training, setting it apart from typical physical therapy that focuses mainly on exercises. Meanwhile, HIPS-2 provides comprehensive lifestyle education covering physical activity, sleep, and nutrition, which isn't commonly integrated into standard hip pain treatments. Both programs are designed to enhance standard care by empowering participants with additional knowledge and skills, potentially leading to better pain management outcomes.

What evidence suggests that this trial's treatments could be effective for hip pain?

Research has shown that physiotherapist-led treatments can reduce pain and improve movement in people with hip pain. Studies indicate that specific physical therapy exercises and relaxation techniques lessen discomfort and boost mobility. In this trial, participants in the HIPS-1 program will engage in mind-body methods that have successfully taught relaxation and coping skills, helping to relieve pain. Meanwhile, participants in the HIPS-2 program will focus on lifestyle education, including exercise and healthy eating, which has improved overall health. Both methods aim to provide non-surgical ways to effectively manage long-term hip pain.46789

Who Is on the Research Team?

KJ

Kate Jochimsen, PhD, ATC

Principal Investigator

Massachusetts General Hospital

Are You a Good Fit for This Trial?

This trial is for adults (18 or older) with chronic hip pain lasting at least 3 months, but without hip arthritis. Participants must have moderate to severe current hip pain, be less physically active than recommended, and feel their hip pain limits activity. They also need to speak English.

Inclusion Criteria

I am at least 18 years old and, if over 45, do not have osteoarthritis on X-ray.
My current hip pain score is 3 or higher on the pain scale.
Psychological risk factor for the maintenance of pain by meeting ≥1 of the criteria listed below:
See 3 more

Exclusion Criteria

I have had surgery on my painful hip.
I currently have pain that starts in my lower back.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Baseline Assessment

Participants complete a digital self-report survey battery before randomization

0 weeks

Treatment

Participants undergo 6 weekly sessions of either HIPS-1 or HIPS-2 intervention delivered via live video

6 weeks
6 sessions (virtual)

Post-Test Assessment

Participants complete survey assessments directly following their final program sessions

0 weeks

Follow-up

Participants are monitored for safety and effectiveness after treatment with a follow-up survey assessment

24 weeks
1 survey assessment (virtual)

What Are the Treatments Tested in This Trial?

Interventions

  • HIPS-1
  • HIPS-2

Trial Overview

The study compares two different live video-based pain management programs (HIPS-1 and HIPS-2), matched in time and intensity, for people with long-term non-arthritic hip pain. Participants are randomly assigned to one of the two programs.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: HIPS-1Experimental Treatment1 Intervention
Group II: HIPS-2Active Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Massachusetts General Hospital

Lead Sponsor

Trials
3,066
Recruited
13,430,000+

National Center for Complementary and Integrative Health (NCCIH)

Collaborator

Trials
886
Recruited
677,000+

Citations

Improving function in people with hip-related pain - PMC

To report the effectiveness of physiotherapist-led interventions in improving pain and function in young and middle-aged adults with hip-related pain.

Hip Pain and Mobility Deficits—Hip Osteoarthritis: Revision ...

The purposes of these clinical guidelines are to: describe evidence-based physical therapy practice, including diagnosis, prognosis, ...

The effects of hip-targeted physical therapy interventions ...

The purpose of this review is to explore the effectiveness of adding physical therapy interventions performed at the hip to standard conservative treatment of ...

Treatment Options for Hip Pain

Non-surgical treatment should always be considered first when treating hip pain. With some conditions, it is possible to resolve the pain with rest.

Hip pain (osteoarthritis) rapid evidence summaries

7% to 23% after hip replacement – conservative estimate assuming missing data had similar pain outcomes. From Garriga 2019. Out of 438 921 primary hip.

Chronic hip pain in adults: Current knowledge and future ...

This narrative review will describe relevant anatomy, causes, assessment, investigation, and management of chronic hip pain.

HIPS Feasibility Randomized Controlled Trial

The goal of this clinical trial is to conduct a randomized controlled trial (RCT) to test the feasibility of two dose- and time-matched pain ...

Hip Pain and Movement Dysfunction Associated With ...

This is an update to the 2014 Clinical Practice Guideline (CPG) for Hip Pain and Movement Dysfunction Associated with Nonarthritic Hip Joint Pain.

Hip pain: : Symptoms, causes and treatment

Hip replacement is an extremely good treatment for arthritis-related hip pain, and modern techniques make the operation very safe with good outcomes.